期刊文献+

系统性红斑狼疮患者外周血单个核细胞CD_(40)及CD_(40)配体分子表达的研究

Expression of CD_(40) and CD_(40) Ligand on Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的 :探讨CD4 0 及CD4 0 配体 (CD4 0L)分子在活跃期SLE患者外周血单个核细胞 (PBMC)上的表达及在SLE发病中的可能作用机制。方法 :采用流式细胞仪检测 13例初发活跃期及 13例复发活跃期SLE患者PBMC表面CD4 0 及CD4 0L分子的表达。结果 :初发及复发活跃期SLE患者PBMC表达CD4 0 分子 (2 5 .94± 10 .10 ) %及 (2 7.34±12 .94) % ,均较正常对照组 (13.99± 5 .2 6 ) %明显升高 (P <0 .0 0 1) ;初发活跃期SLE患者PBMC表达CD4 0L分子 (1.74±1.6 6 ) %较正常对照组 (0 .91± 0 .39) %亦明显升高 (P <0 .0 5 )。初发与复发活跃期SLE患者之间比较PBMC表达CD4 0及CD4 0L分子无显著性差异。结论 :活跃期SLE患者外周血PBMC存在CD4 0 及CD4 0L分子的异常表达 ,提示CD4 0 及CD4 0L分子在SLE患者T、B细胞之间的信号传导及SLE发病机制中可能起着重要的作用。 Objective:To investigate the expression of CD 40 and CD 40 ligand (CD 40L ) on peripheral blood mononuclear cells (PBMC) in patients with systemic lupus erythematosus (SLE) and its role in the pathogenesis of SLE.Methods:The expression of CD 40 and CD 40L on PBMCs in 13 patients with incipient active SLE and 13 patients with relapsed active SLE was determined by flow cytometry.Results:The expression of CD 40 on PBMCs in both groups of SLE patients [(25.94± 10.10 )% for incipient active SLE;(27.34±12.94)% for relapsed active SLE] was significantly higher than that in normal controls(13.99±5.26)%(P<0.001).The expression of CD 40L on PBMCs in patients with incipient active SLE(1.74± 1.66 )% also increased significantly in comparison with normal controls(0.91±0.39%;P<0.05).There were no statistical differences in the expression of CD 40 and CD 40L on PBMCs between the two groups of patients with active SLE.Conclusion:The abnormal expression of CD 40 and CD 40L on PBMCs in patients with active SLE suggests a disturbed CD 40 -CD 40L signal pathway in SLE patients,which may play an important role in the pathogenesis of SLE.
出处 《中国中西医结合肾病杂志》 2001年第11期630-632,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 系统性红斑狼疮 CD40配体 自身免疫性疾病 外周血单个核细胞 Lupus erythematosus CD 40 CD 40 ligand
  • 相关文献

参考文献8

  • 1Tan EM, Cohen AS, Fris JE. et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum, 1982,25:1271 - 1273.
  • 2Grewal IS, Flavell RA. CD40 and CD154 in cell - mediated immunity. Annu Revlmmunol, 1998,16:111 - 135.
  • 3For TM, Aruffo A, Bajorath J, et al. Immune regulation by CD40and its ligand gp39.Annu Rev Immunol, 1996,14:591 - 617.
  • 4Xiao hui Peng, Ahmad Kasran, Petra A. M. Wardam, et al. Accessory signaling by CD40for T cell activation: indiction of Th1 and Th2 cyto kines and synergy with interleukin-12 for interferon- (production. Eur J Immunol, 1996,26:1621 - 1627. )
  • 5Harigal M, Hara M, Fukasawa C, et al. Responsiveness of peripheral blood B cells torecombinant CD40L ligand in patients with systemic lupus erythematosus. Lupus, 1990,8: 227- 233.
  • 6Mohan C, Shi Y, Laman JD, et al. Interaction between CD40 and its ligand gp39 inthe development of murine lupus nephritis. J Immunol, 1995,154:1470 - 1475.
  • 7邓安梅,仲人前,陈孙孝,施笑梅,孔宪涛.系统性红斑狼疮患者外周血单一核细胞CD40L表达增加及其临床意义[J].中华皮肤科杂志,1999,32(4):232-233. 被引量:2
  • 8弓娟琴,陈志强,贾国泉,胡兹嘉,李文忠.系统性红斑狼疮患者外周血单一核细胞CD40/CD40配体mRNA的表达[J].中华皮肤科杂志,2001,34(1):28-30. 被引量:4

二级参考文献7

  • 1颜子颖 王海林(译).精编分子生物学实验指南(第1版)[M].北京:科学出版社,1998.123-126.
  • 2黄培堂 俞炜源等(译).PCR技术实验指南(第1版)[M].北京:科学出版社,1998.4-33.
  • 3Mohan C,J Immunol,1995年,154卷,1470页
  • 4Tan E M,Arthritis Rheum,1982年,25卷,1271页
  • 5黄培堂(译),PCR 技术实验指南,1998年,4页
  • 6颜子颖(译),精编分子生物学实验指南,1998年,123页
  • 7Desai Mehta A,J Clin Invest,1996年,97卷,2063页

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部